Skip to main content

Search

Duke Regional Hospital patient returns home after 3-month COVID-19 treatment
Testing Tool Can Quickly Distinguish Between Viral and Bacterial Infections
Study Confirms Racial Differences in Response to Prostate Cancer Treatment
New Vaccine Blocks COVID-19 and Variants, Plus Other Coronaviruses
Duke University Hospital Celebrates 2000 COVID-19 Patients Discharged
Duke Health Sends Supplies to India to Assist with Covid-19 Crisis
New Insight in How Breast Cancer Drug Works Could Lead to Improvements
NC InCK Launches New Model to Improve Care and Well-Being of Children Insured by Medicaid in Central NC
Duke’s School of Medicine and School of Nursing Rank in Top 10 Nationally
Cancer Repair Mechanism Could Be Potential Drug Target
Investigational Drug for Heart Failure has Little Impact on Exercise Tolerance
Investigational Anti-Clotting Drug Reduces Bleeding Risk Among AF Patients
Few Patients Have Infected Heart Devices Removed Despite Lifesaving Benefits
Duke Schools of Medicine and Nursing Rank in Top 5 for NIH Research Funding
Robert M. Califf Confirmed as Commissioner for the US Food and Drug Administration
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
Duke Human Vaccine Institute Researchers Receive BIAL Award for Vaccine Technology
Incidence of COVID-19 was 8 Times Higher in Unvaccinated vs. Vaccinated Students
Molecule Produced After Skin Injury is Shown to Accelerate Hair Growth
Study Estimates One in Seven U.S. Breast Cancers May Be Over-Diagnosed